Research protocols typically combine TB-500 (5mg twice weekly), BPC-157 (500mcg daily), and KPV (500mcg daily) for synergistic effects on immune modulation, tissue repair, and inflammation suppression
Investigators have examined the compound in animal-model and human work covering sleep architecture, the stress axis, circadian signalling, and, more recently, neuroprotection (PMID 6145137)
Preclinical research has investigated BPC-157 for a wide range of applications, including gastrointestinal healing (ulcers, NSAID-induced gut damage, intestinal permeability), tendon and ligament repair, muscle recovery from crush injuries, peripheral nerve regeneration, and neuroprotection
oral capsules also used TB-500 SubQ
The lightweight, smooth, fast-absorbing texture brings non-greasy daily care